Alpo Vuorio

2.8k total citations
84 papers, 2.0k citations indexed

About

Alpo Vuorio is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alpo Vuorio has authored 84 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 22 papers in Cancer Research and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alpo Vuorio's work include Lipoproteins and Cardiovascular Health (45 papers), Cancer, Lipids, and Metabolism (22 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Alpo Vuorio is often cited by papers focused on Lipoproteins and Cardiovascular Health (45 papers), Cancer, Lipids, and Metabolism (22 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Alpo Vuorio collaborates with scholars based in Finland, United Kingdom and South Africa. Alpo Vuorio's co-authors include Petri T. Kovanen, Kimmo Kontula, Hannu Turtola, Gerald F. Watts, Jaana Kuoppala, Tuomo Polvikoski, Raimo Sulkava, Leena Niinistö, Pirjo Halonen and Matti Haltia and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Alpo Vuorio

79 papers receiving 1.9k citations

Peers

Countries citing papers authored by Alpo Vuorio

Since Specialization

Citations

This map shows the geographic impact of Alpo Vuorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpo Vuorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpo Vuorio more than expected).

Fields of papers citing papers by Alpo Vuorio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpo Vuorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpo Vuorio. The network helps show where Alpo Vuorio may publish in the future.

Co-authorship network of co-authors of Alpo Vuorio

This figure shows the co-authorship network connecting the top 25 collaborators of Alpo Vuorio. A scholar is included among the top collaborators of Alpo Vuorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpo Vuorio. Alpo Vuorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight? 2025 ·Frontiers in Cardiovascular Medicine ·Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen	0
2	European and US Aeromedical Authority Guidance for Neurocognitive Evaluation of Airline Pilots With Mental Disorders 2024 ·Alpo Vuorio, (unknown), Bruce Budowle, Robert Bor	2
3	Extension of heterozygous familial hypercholesterolaemia treatment recommendations by including both low-density lipoprotein and lipoprotein(a) burden: a unique opportunity to improve patient prognosis 2024 ·European Journal of Preventive Cardiology ·Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen	3
4	Commercial Aircraft-Assisted Suicide Accident Investigations Re-Visited—Agreeing to Disagree? 2023 ·Safety ·Alpo Vuorio, Robert Bor, Antti Sajantila, (unknown), Bruce Budowle	1
5	Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment 2023 ·Annals of Medicine ·Alpo Vuorio, Petri T. Kovanen, Frederick J. Raal	2
6	Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing 2022 ·Annals of Medicine ·Alpo Vuorio, Jonas Brinck, Petri T. Kovanen	5
7	Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment 2021 ·Atherosclerosis ·Alpo Vuorio, Frederick J. Raal, Markku Kaste, Petri T. Kovanen	20
8	Black Swan Pandemic and the Risk of Pilot Suicide 2020 ·Frontiers in Public Health ·Alpo Vuorio, Robert Bor	10
9	Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters 2018 ·Nutrients ·Alpo Vuorio, Petri T. Kovanen	9
10	Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia 2018 ·Atherosclerosis ·Alpo Vuorio, Gerald F. Watts, Petri T. Kovanen	29
11	Evacuation Preparedness in the Event of Fire in Intensive Care Units in Sweden: More is Needed 2017 ·Prehospital and Disaster Medicine ·(unknown), (unknown), (unknown), Alpo Vuorio, Michael Haney	9
12	Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition? 2016 ·European Heart Journal ·Alpo Vuorio, Gerald F. Watts, Petri T. Kovanen	10
13	LONG-TERM STATIN THERAPY IS ASSOCIATED WITH BETTER EPISODIC MEMORY IN AGED FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS IN COMPARISON WITH POPULATION CONTROLS 2010 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·(unknown), Annamari Tuulio‐Henriksson, Alpo Vuorio, (unknown), Tommi Härkänen, Seppo Koskinen, Timo Strandberg	1
14	Squalene and Noncholesterol Sterols in Serum and Lipoproteins of Children with and without Familial Hypercholesterolemia 2003 ·Pediatric Research ·(unknown), Helena Gylling, Martti A. Siimes, Alpo Vuorio, Tatu A. Miettinen	25
15	Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences 2001 ·Annals of Medicine ·Alpo Vuorio, Katriina Aalto‐Setälä, Ulla‐Maija Koivisto, Hannu Turtola, Henrik Nissen, Petri T. Kovanen, Tatu A. Miettinen, Helena Gylling, Hanna Oksanen, Kimmo Kontula	45
16	Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme 1998 ·Annals of Medicine ·Katriina Aalto‐Setälä, Heikki Palomäki, Helena E. Miettinen, Alpo Vuorio, Timo Kuusi, Raili Raininko, Oili Salonen, Markku Kaste, Kimmo Kontula	32
17	Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples 1997 ·Molecular and Cellular Probes ·Alpo Vuorio, Lars Paulín, Hannu Turtola, Kimmo Kontula	4
18	Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein 1995 ·New England Journal of Medicine ·Tuomo Polvikoski, Raimo Sulkava, Matti Haltia, Katariina Kainulainen, Alpo Vuorio, Auli Verkkoniemi, Leena Niinistö, Pirjo Halonen, Kimmo Kontula	407
19	A Mutation in the Amino-Terminal End of the Triple Helix of Type II Collagen Causing Severe Osteochondrodysplasia 1993 ·Genomics ·Miikka Vikkula, Pertti Ritvaniemi, Alpo Vuorio, Ilkka Kaitila, Leena Ala-Kokko, Leena Peltonen	29
20	Cryptosporidium in Asymptomatic Children 1991 ·Clinical Infectious Diseases ·Alpo Vuorio, A. M. M. Jokipii, Liisa Jokipii	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact